Influence of obstructive jaundice on pharmacodynamics of rocuronium

PLoS One. 2013 Oct 16;8(10):e78052. doi: 10.1371/journal.pone.0078052. eCollection 2013.

Abstract

Background: Anesthetics are variable in patients with obstructive jaundice. The minimum alveolar concentration awake of desflurane is reduced in patients with obstructive jaundice, while it has no effect on pharmacodynamics and pharmacokinetics of propofol. In this study, we investigated the influence of obstructive jaundice on the pharmacodynamics and blood concentration of rocuronium.

Methods: Included in this study were 26 control patients and 27 patients with obstructive jaundice. Neuromuscular block of rocuronium was monitored by acceleromyography. Onset time, spontaneous recovery of the height of twitch first (T1) to 25% of the final T1 value (Duration 25%, Dur 25%), recovery index (RI), and spontaneous recovery of train-of-four (TOF) ratios to 70% were measured. The plasma rocuronium concentrations were determined by high performance liquid chromatography using berberine as an internal standard.

Results: There was no significant difference in onset time between the two groups. The Dur 25%, the recovery index and the time of recovery of the TOF ratios to 70% were all prolonged in the obstructive jaundice group compared with the control group. The plasma concentration of rocuronium at 60, 90 and 120 min after bolus administration was significantly higher in the obstructive jaundice group.

Conclusions: The neuromuscular blockade by rocuronium is prolonged in obstructive jaundice patients, and therefore precautions should be taken in case of postoperative residual neuromuscular block. The possible reason is impedance of rocuronium excretion due to biliary obstruction and increased plasma unbound rocuronium because of free bilirubin competing with it for albumin binding.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Androstanols / blood
  • Androstanols / pharmacokinetics*
  • Female
  • Humans
  • Jaundice, Obstructive / blood*
  • Jaundice, Obstructive / metabolism*
  • Male
  • Middle Aged
  • Neuromuscular Blockade
  • Rocuronium

Substances

  • Androstanols
  • Rocuronium

Grants and funding

This work was supported by the National Natural Science Foundation of China (81100312); the Innovation Program of Shanghai Municipal Education Committee (12ZZ081); and the Science Program of Fujian Provincal Education Office (JB11053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.